Trending: Wuxi Biologics Licenses Tumor Antibodies to GSK
0458 GMT - Wuxi Biologics (Cayman) Inc. is one of the most mentioned companies in the news over the past six hours, according to Factiva data, after agreeing to license antibodies involving T cells to GSK PLC. Wuxi Biologics…